Financial markets have been shaken by the global outbreak. How great is the risk to your portfolio and what steps should you take? Read More
Analyst Articles
New data show that marijuana is on track to become a $57-billion-a-year mainstream industry. We examine the trends that are fueling the bonanza. Read More
The fast-spreading coronavirus has clobbered global equity markets. Make these moves now, to protect your portfolio from rising investor fear. Read More
We asked our editorial director to pinpoint for investors the opportunities and pitfalls in the months ahead. Read More
The shakeout in the marijuana sector has been brutal, but the survivors are strong and trade at bargain levels. Read More
Earnings are lackluster, valuations are high, trade tensions linger, and leading indicators are weakening. It’s time to get defensive. Read More
Anti-marijuana forces aren’t giving up their efforts to stymie the legalization of weed. But they’re fighting an uphill battle. Read More
We look at the best and worst performing sectors for earnings growth in the fourth quarter. We also examine the S&P 500’s earnings recession. Read More
If your portfolio is properly positioned, you can respond calmly and rationally to unexpected external shocks and sharp downturns. Read More
The contrast in Q4 results between positive revenues and negative earnings is raising questions about net profit margins. Read More